Allogene Therapeutics Announces Participation in Four Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., April 13, 2023 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO),…
SOUTH SAN FRANCISCO, Calif., April 13, 2023 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO),…
BOSTON, April 13, 2023 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company…
BOSTON, April 13, 2023 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company…
BOSTON, April 13, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development…
BOSTON, April 13, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development…
COPENHAGEN, Denmark, April 13, 2023 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced…
COPENHAGEN, Denmark, April 13, 2023 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced…
SEATTLE, April 13, 2023 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company…
SEATTLE, April 13, 2023 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company…
NEW ORLEANS and CAMBRIDGE, England, April 13, 2023 (GLOBE NEWSWIRE) — Revolo Biotherapeutics (“Revolo Bio”…
NEW ORLEANS and CAMBRIDGE, England, April 13, 2023 (GLOBE NEWSWIRE) — Revolo Biotherapeutics (“Revolo Bio”…
REDWOOD CITY, Calif., April 13, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper),…
REDWOOD CITY, Calif., April 13, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper),…
MORRISTOWN, N.J., April 13, 2023 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company…
MORRISTOWN, N.J., April 13, 2023 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company…
Interim data to be presented in an oral presentation by Dr. Arshad M. Khanani, M.D.,…
Interim data to be presented in an oral presentation by Dr. Arshad M. Khanani, M.D.,…
– Interim blinded safety and pharmacokinetic data to be presented at the 33rd European Congress…
– Interim blinded safety and pharmacokinetic data to be presented at the 33rd European Congress…
SAN CARLOS, Calif., April 13, 2023 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a…